Prospective Study
Copyright ©The Author(s) 2016.
World J Nephrol. Sep 6, 2016; 5(5): 471-481
Published online Sep 6, 2016. doi: 10.5527/wjn.v5.i5.471
Table 3 Adjusted Cox proportional hazards models of patient survival (events = 46)
ModelCovariates controlled forAdjusted HR (95%CI)P
0 (Unadjusted)25-hydroxivitamin D levels (mg/dL)0.95 (0.91-0.99)0.009
125-hydroxivitamin D levels (mg/dL) + age0.95 (0.91-0.99)0.009
2Model 1 + diabetes mellitus, ischemic heart disease, chronic heart failure0.96 (0.92-0.99)0.028
3Model 1 + peripheral arterial disease, abnormal ABPI1, phosphorous (mg/dL)0.95 (0.92-0.99)0.023
4Model 1 + DBP (mm Hg), 1,25(OH)2 vitamin D (pg/mL), estimated GFR (mL/min per 1.73 m2)0.96 (0.92-0.99)0.020
5Model 1 + vascular calcification [Kauppila score (log), Adragao score (log)], CKD stage 50.95 (0.91-1.00)0.050
6Model 1 + obesity, hemoglobin (g/L), albumin (g/dL)0.95 (0.92-0.99)0.019

  • Citation: Molina P, Górriz JL, Molina MD, Beltrán S, Vizcaíno B, Escudero V, Kanter J, Ávila AI, Bover J, Fernández E, Nieto J, Cigarrán S, Gruss E, Fernández-Juárez G, Martínez-Castelao A, Navarro-González JF, Romero R, Pallardó LM. What is the optimal level of vitamin D in non-dialysis chronic kidney disease population? World J Nephrol 2016; 5(5): 471-481
  • URL: https://www.wjgnet.com/2220-6124/full/v5/i5/471.htm
  • DOI: https://dx.doi.org/10.5527/wjn.v5.i5.471